Back
Precision BioSciences 10K Form
Sell
12
DTIL
Precision BioSciences
Last Price:
7.70
Seasonality Move:
-6.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-11-10 | 10Q | DTIL/Precision BioSciences Quarterly |
| 2020-08-13 | 10Q | DTIL/Precision BioSciences Quarterly |
| 2020-05-15 | 10Q | DTIL/Precision BioSciences Quarterly |
| 2020-03-10 | 10K | DTIL/Precision BioSciences Annual |
| 2019-11-12 | 10Q | DTIL/Precision BioSciences Quarterly |
| 2019-08-14 | 10Q | DTIL/Precision BioSciences Quarterly |
Receive DTIL News And Ratings
See the #1 stock for the next 7 days that we like better than DTIL
DTIL Financial Statistics
Sales & Book Value
| Annual Sales: | $48.73M |
|---|---|
| Cash Flow: | $-5.98M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $8.67 |
| Price / Book: | 0.99 |
Profitability
| EPS (TTM): | 0.06000 |
|---|---|
| Net Income (TTM): | $8.62M |
| Gross Margin: | -- |
| Return on Equity: | 19.19% |
| Return on Assets: | 5.21% |
Precision BioSciences Earnings Forecast
Key Precision BioSciences Financial Ratios
- The Research & Development expenses have been 109.54% of Revenue.
- The Interest Expense is -3.64% of Operating Income.
- The Net Earning history of DTIL is -125.84% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Precision BioSciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | DTIL |
| CUSIP: | 74019P |
| Website: | precisionbiosciences.com |
Debt
| Debt-to-Equity Ratio: | 0.34 |
|---|---|
| Current Ratio: | 9.22 |
| Quick Ratio: | 8.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DTIL Technical Analysis vs Fundamental Analysis
Sell
12
Precision BioSciences (DTIL)
is a Sell
Is Precision BioSciences a Buy or a Sell?
-
Precision BioSciences stock is rated a Sell
The current Precision BioSciences [DTIL] share price is $8.08. The Score for DTIL is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.